The group adjuvanted with INI-4001 exhibited a slightly higher weight loss during these days that did not reach statistical significance until day 7.
← all excerpts
Vaccination with ancestral SARS-CoV-2 spike adjuvanted with TLR agonists provides cross-protection against XBB.1.
1
—
—